Immunology, Inflammation, & Infectious Disease (3i) Initiative

Highlighting investigators and their pioneering research programs, the Vitae program seeds new collaborations and development strategies by humanizing research through story.

Nearly half of the world’s population is at risk from malaria, with 282 million cases worldwide in 2025. Malaria had been eradicated from the United States during the 1950s but...

A microbe called Turicibacter improves metabolic health and reduces weight gain in mice. The results could lead to new ways to control weight by adjusting gut bacteria.

University of Utah Health Research Office is the engine that powers health sciences research. We provide essential core services, reimagine research education, secure philanthropic support, and everything in between.

Drugs currently in clinical trials for other conditions could help reduce risk of heart attack and stroke for IBD patients. "This could be lifesaving," senior author says.

Disease modeling research suggests that for some cholera outbreaks, prescribing antibiotics more aggressively could slow or stop the spread of the disease and even reduce the likelihood of antibiotic resistance.